首页 › 慢性淋巴细胞白血病 › 哥伦比亚特区 › Washington
Washington DC 慢性淋巴细胞白血病临床试验
22项针对 慢性淋巴细胞白血病的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
招募中1/2 期
- American Oncology Partners of Maryland Pa, Bethesda · 距离 7 英里
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
招募中3 期
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · 距离 7 英里
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
招募中3 期
- GC2202 Study Site 111, Bethesda · 距离 7 英里
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
招募中3 期
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
招募中3 期
- American Oncology Partners of Maryland Pa, Bethesda · 距离 7 英里
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
招募中3 期
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 距离 7 英里
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
招募中2 期
- Maryland Oncology Hematology, Silver Spring · 距离 7 英里
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
招募中早期 I 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
招募中3 期
- American Oncology Partners of Maryland, PA, Bethesda · 距离 7 英里
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
招募中3 期
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · 距离 7 英里
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- National Institute of Health, Bethesda · 距离 7 英里
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
招募中2 期
- American Oncology Partners, PA, Bethesda · 距离 7 英里
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
招募中观察性研究欢迎健康志愿者
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
招募中3 期
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · 距离 7 英里
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · 距离 7 英里
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
其他城市的 慢性淋巴细胞白血病试验
- Boston, MA31 项研究
- Columbus, OH28 项研究
- Durham, NC27 项研究
- Seattle, WA20 项研究
- Rochester, MN18 项研究
- New York City, NY18 项研究
- Houston, TX17 项研究
- Baldwin Park, CA16 项研究
- Milwaukee, WI15 项研究
- Chicago, IL14 项研究
- Cincinnati, OH14 项研究
- Nashville, TN13 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 肺癌41 项研究
- 前列腺癌38 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 卵巢癌23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。